PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportslennox gastaut syndrome
MeSH D065768 - lennox gastaut syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D030342:Inborn genetic diseases
$
Success rate
D000073376:Epileptic syndromes
$
Success rate
D065768: 
Lennox gastaut syndrome
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Accord HealthcareClobazam Clobazam  2019-05-23   
Topiramate Topiramate  2009-03-27   
Ajanta PharmaTopiramate Topiramate  2023-08-15   
Alkem LaboratoriesClobazam Clobazam  2019-09-06   
Topiramate Topiramate  2023-06-20   
AllerganTopiramate Topiramate  2009-03-27   
Amneal PharmaceuticalsClobazam Clobazam  2018-10-22   
ApotexClobazam Clobazam  2020-06-09   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
100%
3/3
Phase 2
100%
3/3
Phase 3
57%
8/14
Approved: 6Overall Success rate: 57%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Alembic Pharmaceuticals
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use